Sign In
Buy NBTX
$38.39
-1.77 (-4.41%)
At Close: Jul 31, 2026
Nanobiotix stock skyrockets on final negotiations with ‘major' drug maker for its cancer treatment
12:56pm, Friday, 05'th May 2023
Nanobiotix SA (EPA:NANO) shares soared 250% to $7.11, on volume of more than 29 million shares, Friday after the France-based clinical biotechnology company said it has entered into final contract ne
The U.S.-listed shares of Nanobiotix S.A. NBTX blasted 221.7% higher on massive volume Friday, to pace all gainers trading on major U.S. exchanges, after the France-based biotechnology company said it
Why is Nanobiotix (NBTX) Stock Up 107% Today?
08:26am, Friday, 05'th May 2023
Nanobiotix (NASDAQ: NBTX ) stock is taking off on Friday after the company revealed details about ongoing contract negotiations for NBTXR3. NBTXR3 is Nanobiotix's treatment in the works for solid tumo
Nanobiotix S.A. (NBTX) Q4 2022 Earnings Call Transcript
06:15pm, Saturday, 29'th Apr 2023
Nanobiotix S.A. (NASDAQ:NBTX ) Q4 2022 Results Conference Call April 25, 2023 8:00 AM ET Company Participants Craig West - SVP, IR Laurent Levy - Co-Founder and CEO Bart Van Rhijn - CFO Conference Cal
NANOBIOTIX to Provide Operational Update and Report Full Year 2022 Financial Results on April 24, 2023
04:15pm, Monday, 17'th Apr 2023
Conference Call and Webcast to be Held at 2:00 PM CEST/8:00 AM EDT on April 25, 2023 PARIS and CAMBRIDGE, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – t
Nanobiotix to Postpone Full Year 2022 Financial Results and Conference Call
04:15pm, Monday, 27'th Mar 2023
PARIS and CAMBRIDGE, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-stage clinical biotechnology company pioneering physics-b
Nanobiotix to Provide Operational Update and Report Full Year 2022 Financial Results on March 28, 2023
04:15pm, Tuesday, 14'th Mar 2023
Conference Call and Webcast to be Held at 2:00 P.M CET/8:00 A.M. EDT on March 29, 2023
NANOBIOTIX to Present at the 5th Annual Evercore ISI HealthCONx Conference
04:15pm, Tuesday, 15'th Nov 2022
PARIS and CAMBRIDGE, Mass., Nov. 15, 2022 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering physics-ba
Nanobiotix S.A. (NBTX) Q3 2022 Earnings Call Transcript
11:12am, Friday, 11'th Nov 2022
Nanobiotix S.A. (NASDAQ:NBTX ) Q3 2022 Earnings Call Transcript November 10, 2022 8:00 AM ET Company Participants Kate Mcneil - Senior Vice President, Investor Relations Laurent Levy - Co-Founder & Ch
NANOBIOTIX to Present at the Jefferies London Healthcare Conference
04:15pm, Monday, 31'st Oct 2022
PARIS and Cambridge, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering physics-b
NANOBIOTIX to Announce Third Quarter 2022 Financial Results on November 9, 2022
04:15pm, Thursday, 27'th Oct 2022
Conference Call and Webcast to be Held at 8:00 AM ET / 2:00 PM CET on November 10, 2022 Conference Call and Webcast to be Held at 8:00 AM ET / 2:00 PM CET on November 10, 2022
Nanobiotix S.A (NBTX) Q2 2022 Earnings Call Transcript
02:08pm, Thursday, 29'th Sep 2022
Nanobiotix S.A (NASDAQ:NBTX ) Q2 2022 Earnings Conference Call September 29, 2022 8:00 AM ET Company Participants Laurent Levy - Co-Founder, CEO Bart Van Rhijn - CFO Kate McNeil - IR Conference Call P
Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022
04:15pm, Thursday, 22'nd Sep 2022
PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $NBTX #NBTXNews--Regulatory News: NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pio
Nanobiotix's (NBTX) CEO Laurent Levy on Q1 2022 Results - Earnings Call Transcript
02:43pm, Thursday, 19'th May 2022
Nanobiotix S.A. (NASDAQ:NBTX ) Q1 2022 Earnings Conference Call May 19, 2022 8:00 AM ET Company Participants Kate McNeil – Senior Vice President, Investor Relations Laurent Levy – Co-Founder and C
NANOBIOTIX to Present During the Jefferies Healthcare Conference in June 2022
04:15pm, Tuesday, 17'th May 2022
PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering physics-bas
